|
| 回到 StockQ 正常版首頁 |
|
| 技術線圖 |
| 5日平均 | 10日平均 | 20日平均 |
| 3308.41 | 3293.93 | 3308.24 |
| 60日平均 | 120日平均 | 260日平均 |
| 3221.08 | 3139.81 | 2602.59 |
| Date | Price | Change% |
| 2026/02/13 | 3275.9585 | -1.57% |
| 2026/02/12 | 3328.063 | 1.32% |
| 2026/02/11 | 3284.735 | -1.08% |
| 2026/02/10 | 3320.537 | -0.37% |
| 2026/02/09 | 3332.7695 | 2.98% |
| 2026/02/06 | 3236.4644 | -0.73% |
| 2026/02/05 | 3260.278 | -1.55% |
| 2026/02/04 | 3311.515 | -0.40% |
| 2026/02/03 | 3324.8923 | 1.86% |
| 2026/02/02 | 3264.1108 | -2.46% |
| 2026/01/30 | 3346.3552 | 1.27% |
| 2026/01/29 | 3304.51 | -0.57% |
| 2026/01/28 | 3323.562 | -0.57% |
| 2026/01/27 | 3342.599 | 0.71% |
| 2026/01/26 | 3319.149 | -0.91% |
| 2026/01/23 | 3349.5034 | 0.63% |
| 2026/01/22 | 3328.6472 | 1.01% |
| 2026/01/21 | 3295.523 | 0.54% |
| 2026/01/20 | 3277.979 | -1.79% |
| 2026/01/19 | 3337.6082 | -0.70% |
相關基金績效 (可點按欄位名稱排序)
| 名稱 | 三個月 | 六個月 | 一年 | 今年 |
| 創業板指指數 | 25.47% | 19.88% | 42.61% | 17.22% |
| 聯博中國優化波動股票基金-A股/美元 | 4.47% | -3.17% | -12.52% | 2.34% |
| 聯博中國優化波動股票基金-A股/歐元 | 2.85% | -5.25% | -15.61% | 3.30% |
| 聯博中國A股基金-A2類型/台幣 | 8.73% | 28.37% | 30.68% | 5.14% |
| 聯博中國A股基金-A2類型/美元 | 7.44% | 22.51% | 36.52% | 5.10% |
| 聯博中國A股基金-A2類型/人民幣 | 4.06% | 17.47% | 28.78% | 3.78% |
| 富達中國聚焦基金/美元 | -2.98% | 6.24% | 23.19% | 3.22% |
| 法巴中國股票基金-C股/美元 | 18.77% | 22.80% | 31.79% | 18.92% |
| 安聯中國策略基金/台幣 | 13.94% | 37.61% | 36.51% | 5.68% |
| 安聯中國股票基金-A股/配息/美元 | -4.04% | 5.99% | 25.55% | 3.64% |
| 霸菱香港中國基金-A類/配息/歐元 | -2.44% | 7.99% | 7.53% | 3.59% |
| 霸菱香港中國基金-A類/配息/美元 | -0.32% | 9.29% | 22.60% | 4.57% |
| 霸菱香港中國基金-A類/配息/英鎊 | -3.65% | 9.01% | 12.44% | 3.44% |
| 貝萊德中國基金A2/美元 | -2.91% | 4.68% | 16.21% | 2.19% |
| 貝萊德中國基金A2-歐元避險 | -3.46% | 3.43% | 13.04% | 1.82% |
| 貝萊德中國基金A2-澳幣避險 | -3.27% | 3.99% | 13.79% | 1.89% |
| 群益華夏盛世基金/台幣 | 10.32% | 30.13% | 25.67% | 7.38% |
| 群益華夏盛世基金/美元 | 8.93% | 24.16% | 31.26% | 7.29% |
| 群益華夏盛世基金/人民幣 | 5.57% | 19.06% | 23.84% | 5.90% |
| 群益中國新機會基金/台幣 | 10.70% | 25.50% | 23.04% | 7.93% |
| 群益中國新機會基金/美元 | 9.33% | 19.84% | 28.54% | 7.87% |
| 群益中國新機會基金/人民幣 | 5.95% | 14.92% | 21.28% | 6.47% |
| DWS投資中國股票基金E2/美元 | 3.65% | 17.91% | 23.93% | 15.77% |
| DWS投資中國股票基金A2/美元 | 14.96% | 19.61% | 24.27% | 15.09% |
| DWS投資中國股票基金FC/歐元 | -2.39% | 3.13% | 13.75% | 2.31% |
| DWS投資中國股票基金LC/歐元 | 8.52% | 5.45% | 15.14% | 2.42% |
| 瀚亞中國基金/台幣 | 6.49% | 32.14% | 39.95% | 3.78% |
| 瀚亞中國股票基金/美元 | -4.76% | 5.74% | 25.72% | -0.61% |
| 愛德蒙得洛希爾中國基金(A)/歐元 | -1.76% | 3.10% | 23.33% | 2.06% |
| 愛德蒙得洛希爾中國基金(A)/美元 | 3.84% | 17.76% | 34.15% | 15.82% |
| 歐義銳榮中國股票基金-R/歐元 | -3.15% | 6.34% | 9.04% | 2.79% |
| 歐義銳榮中國股票基金-R2/美元 | -0.94% | 8.75% | 25.05% | 3.80% |
| 首域盈信中國核心基金/美元 | 9.16% | 12.40% | 18.57% | 6.94% |
| 富蘭克林華美中國消費基金/台幣 | 8.19% | 20.44% | 17.13% | 3.89% |
| 富蘭克林華美中國傘型基金之中國A股基金/台幣 | 10.69% | 24.53% | 17.99% | 5.92% |
| 富蘭克林華美中國傘型基金之中國A股基金/人民幣 | 5.93% | 13.57% | 16.42% | 4.74% |
| 富蘭克林華美中國傘型基金之中國A股基金/美元 | 9.18% | 18.34% | 23.17% | 5.69% |
| 復華華人世紀基金/台幣 | 21.30% | 55.16% | 90.28% | 21.54% |
| 復華大中華中小策略基金/台幣 | 20.19% | 48.29% | 42.40% | 14.81% |
| 匯豐中國動力基金-台幣 | 17.15% | 38.45% | 42.56% | 11.85% |
| 匯豐中國股票基金AD/美元 | 13.70% | 18.83% | 17.02% | 13.93% |
| 景順中國基金-A股/美元 | -1.81% | 7.37% | 20.78% | 3.39% |
| 景順中國基金-A股/歐元對沖 | -2.33% | 6.02% | 18.28% | 3.12% |
| 景順中國基金-A股/澳幣對沖 | -2.11% | 6.69% | 19.06% | 3.19% |
| 摩根中國基金-A股/分派/美元 | -3.08% | 7.11% | 20.27% | 1.51% |
| 木星中國基金-ACC/美元 | -7.75% | -3.82% | -6.93% | -12.97% |
| 木星中國基金–ACC/英鎊 | 13.43% | 16.64% | 37.41% | 13.75% |
| 野村中國機會基金/台幣 | 11.57% | 24.55% | 29.13% | 5.64% |
| 鋒裕匯理-中國股票基金-A2/美元 | 4.07% | 17.28% | 24.44% | 15.57% |
| 鋒裕匯理-中國股票基金-B2/美元 | 3.90% | 16.86% | 23.56% | 15.21% |
| 鋒裕匯理-中國股票基金-A2/歐元 | -1.77% | 2.48% | 14.18% | 1.67% |
| 荷寶中國股票基金-D/歐元 | -10.74% | -12.16% | -24.25% | -23.76% |
| 荷寶中國股票基金-D/美元 | -5.71% | -10.92% | -21.01% | -20.63% |
| 新光中國成長基金/台幣 | 9.38% | 25.75% | 18.20% | 17.32% |
| 瑞銀(盧森堡)中國精選股票基金/美元 | -1.93% | 5.68% | 25.09% | 2.89% |
| 瑞銀(盧森堡)中國精選股票基金-月配息/美元 | -2.41% | 4.65% | 22.66% | 2.72% |
| 元大新中國基金/台幣 | 10.04% | 28.35% | 17.69% | 5.16% |
| ( 中國基金 ) | 4.30% | 14.59% | 21.12% | 5.32% |
| ||||||||||||
|
StockQ 全球股市指數 © All rights reserved.
|